April 25-26, 2026
Beijing, China
AOGIN
1.HPV and Host Transcriptional Dynamics
2.HPV DNA Damage Replication and Carcinogenic Progression
3.Molecular Mechanisms of HPV Pathogenesis and Immune Response
4.HPV Virology, Genotype Distribution, and Pathogenic Mechanisms
5.HPV Prevention and Implementation Science
6.New HPV Preventive Vaccines and Therapeutic Vaccines
7.New Detection Technologies, Screening Methods, and Self-Sampling
8.New Biomarkers as Prognostic Predictors of Disease
9.HPV Prevention, Screening, and Treatment in Low-Resource Settings and Hard-to-Reach Populations
10.Health Education, Public Awareness, Vaccine Acceptance, and Socio-Cultural Barriers
11.HPV and Cervical Cancer Prevention in Women with HIV Co-Infection
12.Progress and Applications of HPV Vaccines for Men
13.Prevention and Treatment of HPV-Driven Head and Neck Cancers
14.Prevention and Treatment of Vaginal, Vulvar, Anal Tumors, and Genital Infections
15.Latest Advances in Health Economics and Mathematical Modeling for Cervical Cancer Prevention
16.Application of Artificial Intelligence and Digital Educational Tools in Cervical Cancer Prevention and Control
第23次中国癌症基金会宫颈癌协作组会议暨亚洲-大洋洲生殖器感染和肿瘤研究组织 (AOGIN)学术大会


